Planning to launch clinical trials for its first product by mid-2023, the Y Combinator alum could have big implications for life sciences in Pittsburgh.
Mindstate Design is a Pennsylvania-based biotechnology company that develops and commercializes psychedelic-inspired therapeutics for the treatment of mental health disorders.